For: | Kasai K, Ushio A, Sawara K, Miyamoto Y, Kasai Y, Oikawa K, Kuroda H, Takikawa Y, Suzuki K. Transcatheter arterial chemoembolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma. World J Gastroenterol 2010; 16(27): 3437-3444 [PMID: 20632449 DOI: 10.3748/wjg.v16.i27.3437] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i27/3437.htm |
Number | Citing Articles |
1 |
Kentarou Otsuji, Koji Takai, Yoichi Nishigaki, Shougo Shimizu, Hideki Hayashi, Kenji Imai, Yusuke Suzuki, Tatsunori Hanai, Takayasu Ideta, Tsuneyuki Miyazaki, Eiichi Tomita, Masahito Shimizu, Hisataka Moriwaki. Efficacy and safety of cisplatin versus miriplatin in transcatheter arterial chemoembolization and transarterial infusion chemotherapy for hepatocellular carcinoma: A randomized controlled trial. Hepatology Research 2015; 45(5): 514 doi: 10.1111/hepr.12376
|
2 |
Satoru Murata, Takahiko Mine, Tatsuo Ueda, Ken Nakazawa, Shiro Onozawa, Daisuke Yasui, Shin-ichiro Kumita, Takeshi Fujita, Satoshi Kobayashi. Transcatheter Arterial Chemoembolization Based on Hepatic Hemodynamics for Hepatocellular Carcinoma. The Scientific World Journal 2013; 2013(1) doi: 10.1155/2013/479805
|
3 |
Shiro Miyayama. Treatment Strategy of Transarterial Chemoembolization for Hepatocellular Carcinoma. Applied Sciences 2020; 10(20): 7337 doi: 10.3390/app10207337
|
4 |
Masatoshi Kudo, Kazuho Imanaka, Nobuyuki Chida, Kohei Nakachi, Won-Young Tak, Tadatoshi Takayama, Jung-Hwan Yoon, Takeshi Hori, Hiromitsu Kumada, Norio Hayashi, Shuichi Kaneko, Hirohito Tsubouchi, Dong Jin Suh, Junji Furuse, Takuji Okusaka, Katsuaki Tanaka, Osamu Matsui, Michihiko Wada, Iku Yamaguchi, Toshio Ohya, Gerold Meinhardt, Kiwamu Okita. Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma. European Journal of Cancer 2011; 47(14): 2117 doi: 10.1016/j.ejca.2011.05.007
|
5 |
Qiang Li, Lin-Zhong Zhu, Ren-Jie Yang, Xu Zhu. Cytotoxic Activity of Anticancer Drugs on Hepatocellular Carcinoma Cells in Hypoxic-Hyponutritional Culture. International Surgery 2014; 99(6): 745 doi: 10.9738/INTSURG-D-14-00073.1
|
6 |
Shiro Miyayama, Masashi Yamashiro, Yoshihiro Shibata, Masahiro Hashimoto, Miki Yoshida, Kazunobu Tsuji, Fumihito Toshima, Osamu Matsui. Comparison of local control effects of superselective transcatheter arterial chemoembolization using epirubicin plus mitomycin C and miriplatin for hepatocellular carcinoma. Japanese Journal of Radiology 2012; 30(3): 263 doi: 10.1007/s11604-011-0043-6
|
7 |
Alberta Cappelli, Rita Golfieri, Violante Mulas, Antonio De Cinque, Cristina Mosconi. Transarterial Chemoembolization (TACE). 2023; : 39 doi: 10.1007/978-3-031-36261-3_6
|
8 |
Joong‐Won Park, Deepak Amarapurkar, Yee Chao, Pei‐Jer Chen, Jean‐Francois H. Geschwind, Khean Lee Goh, Kwang‐Hyub Han, Masatoshi Kudo, Han Chu Lee, Rheun‐Chuan Lee, Laurentius A. Lesmana, Ho Yeong Lim, Seung Woon Paik, Ronnie T Poon, Chee‐Kiat Tan, Tawesak Tanwandee, Gaojun Teng, Ann‐Lii Cheng. Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC). Liver International 2013; 33(3): 327 doi: 10.1111/liv.12083
|
9 |
Toru Ishikawa. Treatment Strategy for Recurrent Multiple Hepatocellular Carcinoma. Journal of Cancer Therapy 2013; 4(02): 408 doi: 10.4236/jct.2013.42A049
|
10 |
Yuki Tomozawa, Norihisa Nitta, Shinji Ohta, Hideji Otani, Shobu Watanabe, Akinaga Sonoda, Keiko Tsuchiya, Ayumi Nitta-Seko, Masashi Takahashi, Kiyoshi Murata. Antitumor effect of miriplatin-lipiodol suspension/emulsion using a VX2 liver tumor model. Japanese Journal of Radiology 2013; 31(10): 662 doi: 10.1007/s11604-013-0231-7
|
11 |
Shyam S. Agrawal, Namita Kaushik. Evaluation of the antimetastatic and antitumor activity, of antibody loaded pemetrexed nanoparticles, in DEN-HepG2 hepatocarcinoma model. International Journal of Surgery Oncology 2018; 3(1): e48 doi: 10.1097/IJ9.0000000000000048
|
12 |
Kenji Ikeda. Recent advances in medical management of hepatocellular carcinoma. Hepatology Research 2019; 49(1): 14 doi: 10.1111/hepr.13259
|